The invention relates to an imidazolidine derivative represented by the following general formula (1):
 wherein A and B mean individually an aromatic hydrocarbon group which may be substituted by 1-3 substituents selected from halogen atoms, C1-4 alkyl groups, C1-4 alkoxy groups, C1-4 alkylenedioxy groups, a phenoxy group, a nitro group, a cyano group, a phenyl group, C2-5 alkanoylamino groups, a carboxyl group which may be esterified with a C1-4 alkyl or alkenyl group, carboxyalkyl groups which may be esterified with a C1-4 alkyl or alkenyl group, carboxyalkyloxy groups which may be esterified with a C1-4 alkyl or alkenyl group, N-alkylpiperazinylcarbonyl groups, N-alkylpiperazinylcarbonylalkyl groups, N-alkylpiperazinylcarbonylalkyloxy groups, and a morpholinocarbonyl group; X denotes a sulfonyl or carbonyl group; and Y stands for an oxygen or sulfur atom, a chymase inhibitor comprising the same as an active ingredient, and a medicine comprising the same as an active ingredient, typified by a prophylactic and therapeutic agent for a disease of the heart or circulatory system, which is caused by the abnormal acceleration of production of angiotensin II.
                            本发明涉及一种由以下通式(1)代表的
咪唑烷衍
生物:
 其中 A 和 B 分别指可被 1-3 个取代基取代的
芳香烃基团,这些取代基选自卤素原子、C1-4 烷基、C1-4 烷氧基、C1-4 亚烷氧基、苯氧基、硝基、
氰基、苯基、C2-5 烷
氨基、可与 C1-4 烷基或烯基酯化的羧基、可与 C1-4 烷基或烯基酯化的羧烷基、可与 C1-4 烷基或烯基酯化的羧烷基、可与 C1-4 烷基或烯基酯化的羧烷基、可与 C1-4 烷基或烯基酯化的羧烷基、可与 C1-4 烷基或烯基酯化的羧烷基、可与 C1-4 烷基或烯基酯化的羧基烷基、可与 C1-4 烷基或烯基酯化的羧基烷氧基、N-烷基
哌嗪基羰基、N-烷基
哌嗪基羰基烷基、N-烷基
哌嗪基羰基烷氧基和吗啉基羰基;X 表示磺酰基或羰基;Y 表示氧原子或
硫原子,包括作为活性成分的糜蛋白酶抑制剂,以及包括作为活性成分的药物,典型的是用于预防和治疗
血管紧张素 II 异常加速分泌引起的心脏或循环系统疾病的药物。